Investor alert: law offices of howard g. smith announces investigation of provention bio, inc. (prvb) on behalf of investors

Bensalem, pa.--(business wire)---- $prvb #classaction--law offices of howard g. smith announces an investigation on behalf of provention bio, inc. ("provention" or the "company") (nasdaq: prvb) investors concerning the company's possible violations of federal securities laws. in november 2020, provention completed the rolling submission of a biologics license application ("bla") to the u.s. food and drug administration ("fda") for teplizumab for the delay or prevention of clinical t1d in at-risk individuals (the "tep
PRVB Ratings Summary
PRVB Quant Ranking